Virtual Biopsy Market 2025–2034 – M&A Opportunities, AI Integration, and Competitive Benchmarking

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What is the anticipated market size of the virtual biopsy industry over the next few years?
The virtual biopsy market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.71 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing demand for non-invasive diagnostic methods, growing preference for early disease detection, rising efficiency in medical imaging software, increasing patient convenience and comfort, and rising availability of telemedicine services.

The virtual biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.12 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to a growing focus on cost-effective healthcare solutions, a growing focus on preventive healthcare measures, a growing demand for personalized medicine, a rising demand for minimally invasive cancer treatments, and the growing importance of precision oncology. Major trends in the forecast period include developing imaging sensors, developing multimodal biopsy techniques, integration with robotics for precision, innovation in non-invasive biomarker detection, and integration with three-dimensional (3D) visualization tools.

Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp

What emerging drivers are expected to shape the future of the virtual biopsy market?
The rising prevalence of oncological disorders is expected to propel the growth of the virtual biopsy market going forward. Oncological disorders are health conditions related to cancer, where abnormal cells grow and spread in the body. The rising prevalence of oncological disorders is primarily due to lifestyle changes such as poor diet, physical inactivity, tobacco use, and increasing exposure to environmental pollutants. Virtual biopsy enhances the diagnosis and monitoring of oncological disorders by providing non-invasive, real-time imaging insights that reduce the need for traditional tissue biopsies while improving accuracy and patient safety. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of cancer cases diagnosed in Australia rose to 160,570 in 2022, marking an increase of 3,789 cases compared to 156,781 in 2021. Therefore, the rising prevalence of oncological disorders is driving the growth of the virtual biopsy market.

What emerging segments are shaping the future landscape of the virtual biopsy industry?
The virtual biopsy market covered in this report is segmented –

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas
2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds
3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies
4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:
1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers
2) By Neurological Disorders: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions
3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions
4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders
5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions
6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions
7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

What are the key trends shaping the virtual biopsy market in the forecast period?
Major companies operating in the virtual biopsy market are focusing on developing technologically advanced solutions and getting approvals, such as the magnetic resonance spectroscopy (MRS) platform, to enhance non-invasive diagnostic accuracy and provide real-time analysis for early disease detection and personalized treatment. Magnetic resonance spectroscopy (MRS) is a non-invasive imaging technique that helps virtual biopsy by providing detailed molecular information of tissues, enabling accurate, real-time disease detection and monitoring without the need for invasive procedures. For instance, in November 2023, BrainSpec Inc., a US-based healthtech company, received approval from the U.S. Food and Drug Administration (FDA) for the artificial intelligence (AI)-driven BrainSpec platform. This technology uses advanced artificial intelligence (AI) analysis of MR spectroscopy data to measure brain metabolites such as 2-hydroxyglutarate, facilitating non-invasive virtual biopsies for the diagnosis of conditions such as gliomas, alzheimer’s, and multiple sclerosis. The system integrates seamlessly with standard magnetic resonance imaging (MRI) scanners, automates data processing, and provides results within minutes. It also utilizes a reference database of brain chemistry to improve diagnostic accuracy.

How are key players in the virtual biopsy market strengthening their market position?
Major companies operating in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc, ImageBiopsy Lab GmbH, AI Metrics LLC, Deep Bio Inc.

Which geographic areas are contributing significantly to the growth of the virtual biopsy sector?
North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can Companies Use The Virtual Biopsy Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp

Need Customized Data On Virtual Biopsy Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info


Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Ammonia Market Forecast 2025 – Industry Trends, Challenges & Strategic Intelligence

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. How has the ammonia grown historically, and what trends indicate future expansion? The ammonia market size has grown strongly in recent years. It will grow from $79.13 billion in 2024 to $85.57 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to agricultural demand, expanding population, energy and power generation, chemical manufacturing:. The ammonia market size is expected to see strong growth in the next few years. It will grow to $124.86 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to hydrogen economy development, renewable energy, carbon capture and storage (ccs), clean energy transition. Major trends in the forecast period includ...
Read more

Poultry Disinfectant Market Outlook 2025 – Global Demand, Trends & Forecast

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the poultry disinfectant industry by 2029? The poultry disinfectant market size has grown strongly in recent years. It will grow from $4.67 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to demand for biosecurity and disease prevention, growth in poultry farming and agriculture, expansion of food safety regulations, use in hatcheries and broiler farms, regulatory standards for poultry hygiene. The poultry disinfectant market size is expected to see rapid growth in the next few years. It will grow to $7.78 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to sustainable and eco-frie...
Read more

Ammonium Sulfate Market Outlook 2025–2034 – Forecast, Trends & Growth Strategies

 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Ammonium Sulfate industry. What is the projected value of the ammonium sulfate market by 2029? The ammonium sulfate market size has grown strongly in recent years. It will grow from $3.88 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to economic growth, agriculture demand, government subsidies, population growth, rise in chemical industry. The ammonium sulfate market size is expected to see strong growth in the next few years. It will grow to $6.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing crop yields, environmental regulations, food security concerns, rising pharmaceuticals sector, rise in disposable income. Major ...
Read more